Vistin Pharma ASA (VISTN) Ordinary Shares NOK1
Sell:24.60 NOKBuy:25.00 NOK
No change
Prices delayed by at least 15 minutes
- This stock can be held in a
Stocks and Shares ISASell:24.60 NOK
Buy:25.00 NOK
Change:No change
No changePrices delayed by at least 15 minutes
Sell:24.60 NOK
Buy:25.00 NOK
Change:No change
No changePrices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 26 September 2024 | SAGA PURE ASAInvestment Management Company | Buy Regular purchase transaction | 50,000 | 28.20 NOK | 1,410,000.00 NOK | 700,000 |
| 13 September 2024 | SAGA PURE ASAInvestment Management Company | Buy Regular purchase transaction | 250,000 | 25.13 NOK | 6,282,500.00 NOK | 650,000 |
| 23 August 2024 | SAGA PURE ASAInvestment Management Company | Buy Regular purchase transaction | 300,000 | 22.50 NOK | 6,750,000.00 NOK | 400,000 |
| 22 March 2024 | PACTUM ASFamily Holding | Sell Regular sell transaction (market) | 527,960 | 22.10 NOK | 11,667,916.00 NOK | 2,991,773 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 22 March 2024 | PACTUM ASFamily Holding | Sell Regular sell transaction (market) | 527,960 | 22.10 NOK | 11,667,916.00 NOK | 2,991,773 |
| 23 August 2024 | SAGA PURE ASAInvestment Management Company | Buy Regular purchase transaction | 300,000 | 22.50 NOK | 6,750,000.00 NOK | 400,000 |
| 13 September 2024 | SAGA PURE ASAInvestment Management Company | Buy Regular purchase transaction | 250,000 | 25.13 NOK | 6,282,500.00 NOK | 650,000 |
| 26 September 2024 | SAGA PURE ASAInvestment Management Company | Buy Regular purchase transaction | 50,000 | 28.20 NOK | 1,410,000.00 NOK | 700,000 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.